I am back and need to catch up on the overall market and some sector news. I do want to focus today on a stock we all know and will.
The market is in an odd position in that it is doing well with macro having faded into the background. I would keep an eye on the Iran situation flaring.
Pfizer (PFE) presented its first set of data (n=6) from the mini-dystrophin gene therapy for DMD (PF-06939926) at the PPMD conference on June 28th. Much speculations surrounded Pfizer’s decision to.
A good start to the morning for the sector, although it seems mostly in line with the broader markets. Given the performance the past couple days, however, I am happy.
The sector is in an interesting spot. Tensions with Iran remain elevated but did not escalate, which should lead to a risk on move and while the market was tepidly.
We got a very nice follow through during the day yesterday for the sector. That is exactly what you wanted to see and ideally it continues for the next couple.
It is Friday again, so be on the lookout for those rumors or late day runners. A slow start to the morning in terms of price action but we are.
Nothing has really changed. Oddly the sector is really underperforming the market today at the start, which is not good but at least we are seeing an end to the.
Guess what? The macro continues to dominate but it might actually work for us this week. If Mexico can work out a deal with the US, then the market is.
Macro, Macro, Macro. I am sort of getting sick of it but at least it is working to the upside today (at least for now). Hopefully with ASCO coming this.